A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer
References
- 1. Prasad D, Schiff D. Malignant spinal cord compression. Lancet Oncol 2005; 6: 15-24.
- 2. Rades D, Abrahm JL.The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 2010; 7: 590-8.
- 3. Rades D, Douglas S, Veninga T, Stalpers LJA, Hoskin PJ, Bajrovic A, et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 2010; 116: 3670-3.
- 4. Rades D, Rudat V, Veninga T, Stalpers LJA, Bazic H, Karstens JH, et al. A score predicting post-treatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2008; 72: 905-8.
- 5. Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 2012; 24: 112-24.
- 6. Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005; 23: 3358-65.
- 7. Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005; 23: 3366-75.
- 8. Patchell R, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005; 366: 643-8.
- 9. Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006; 24: 3388-93.
- 10. Rades D, Lange M, Veninga T, Stalpers LJA, Bajrovic A, Adamietz IA, et al. Final results of a prospective study comparing the local control of shortcourse and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2011; 79: 524-30.
- 11. Rades D, Panzner A, Rudat V, Karstens JH, Schild SE. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol 2011; 187: 729-35.
- 12. Rose PS, Laufer I, Boland PJ, Hanover A, Bilsky MH, Yamada J, et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 2009; 27: 5075-9.
- 13. Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, et al. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 2012; 118: 5069-77.
- 14. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79: 965-76.
- 15. Chawla S, Schell MC, Milano MT. Stereotactic body radiation for the spine: a review. Am J Clin Oncol 2013; 36: 630-6.
Language: English
Page range: 86 - 90
Submitted on: Jun 29, 2014
Accepted on: Sep 29, 2014
Published on: Mar 3, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2015 Dirk Rades, Stefan Huttenlocher, Amira Bajrovic, Johann H. Karstens, Tobias Bartscht, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.